Clinical Trials List
2009-01-01 - 2014-10-31
Phase III
Terminated5
-
Trial Applicant
MERCK LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林昭君 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Kon-Ping Lin Division of Neurology
- 張豐基 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 盧相如 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chin-Chang Huang Division of Neurology
- Hong-Chou Kuo Division of Neurology
- 呂榮國 Division of Neurology
- 張宏旭 Division of Neurology
- 朱俊哲 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jen Jen and I Su Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
642 participants
